SMASH-U: A proposal for etiologic classification of intracerebral hemorrhage

Stroke

Volumn 43, Issue 10, 2012, Pages 2592-2597

  Meretoja, Atte ^a,c,d   Strbian, Daniel ^a   Putaala, Jukka ^a   Curtze, Sami ^a   Haapaniemi, Elena ^a   Mustanoja, Satu ^a   Sairanen, Tiina ^a   Satopää, Jarno ^b   Silvennoinen, Heli ^a   Niemelä, Mika ^b   Kaste, Markku ^a   Tatlisumak, Turgut ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Department of Neurosurgery ^*  (Finland)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

amyloid angiopathy; anticoagulation; etiology; hypertension; ICH; stroke

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ADULT; AGED; ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAVERNOMA; CLASSIFICATION; CLINICAL EXAMINATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIABETES MELLITUS; DIGITAL SUBTRACTION ANGIOGRAPHY; FATALITY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; HYPERTENSIVE ANGIOPATHY; ISCHEMIC HEART DISEASE; LIVER CIRRHOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; REVIEW; RISK ASSESSMENT; SMASH U ETIOLOGIC CLASSIFICATION; STROKE; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; SURVIVAL; SYSTEMIC DISEASE; THROMBOCYTOPENIA; VASCULAR AMYLOIDOSIS; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL HEMORRHAGE; CLASSIFICATION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; VASCULAR DISEASES;

EID: 84866700229     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.661603     Document Type: Review

References (29)

1. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
2. Adams HP Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41. (Pubitemid 23014379)
3. Marnane M, Duggan CA, Sheehan OC, Merwick A, Hannon N, Curtin D, et al. Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke study. Stroke. 2010;41:1579-1586.
4. Steiner T, Petersson J, Al-Shahi Salman R, Christensen H, Cordonnier C, Csiba L, et al. European research priorities for intracerebral haemorrhage. Cerebrovasc Dis. 2011;32:409-419.
5. Hatano S. WHO Stroke control programme. WHO Chron. 1972;26: 456-458.
6. Meretoja A, Putaala J, Tatlisumak T, Atula S, Artto V, Curtze S, et al. Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke. 2010;41:1450-1458.
7. Strbian D, Sairanen T, Meretoja A, Pitkaniemi J, Putaala J, Salonen O, et al. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis. Neurology. 2011;77:341-348.
8. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001;56:537-539. (Pubitemid 32172884)
9. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27:1304-1305. (Pubitemid 26286157)
10. Hemphill JC III, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891-897.
11. Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, et al. Transient ischemic attack-proposal for a new definition. N Engl J Med. 2002;347:1713-1716. (Pubitemid 35340795)
12. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167-176.
13. Lovelock CE, Molyneux AJ, Rothwell PM. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol. 2007;6: 487-493.
14. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke. 1995;26:1471-1477.
15. Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke. 2006;37:256-262. (Pubitemid 43732088)
16. Huhtakangas J, Tetri S, Juvela S, Saloheimo P, Bode MK, Hillbom M. Effect of increased warfarin use on warfarin-related cerebral hemorrhage: a longitudinal population-based study. Stroke. 2011;42:2431-2435.
17. Al-Shahi Salman R, Labovitz DL, Stapf C. Spontaneous intracerebral haemorrhage. BMJ. 2009;339:b2586.
18. Hirohata M, Yoshita M, Ishida C, Ikeda SI, Tamaoka A, Kuzuhara S, et al. Clinical features of non-hypertensive lobar intracerebral hemorrhage related to cerebral amyloid angiopathy. Eur J Neurol. 2010;17:823-829.
19. Jackson CA, Sudlow CL. Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage? J Neurol Neurosurg Psychiatry. 2006;77:1244-1252. (Pubitemid 44654755)
20. Weimar C, Benemann J, Terborg C, Walter U, Weber R, Diener HC. Recurrent stroke after lobar and deep intracerebral hemorrhage: a hospital-based cohort study. Cerebrovasc Dis. 2011;32:283-288.
21. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med. 2004;164:880-884. (Pubitemid 38520629)
22. Flaherty ML, Tao H, Haverbusch M, Sekar P, Kleindorfer D, Kissela B, et al. Warfarin use leads to larger intracerebral hematomas. Neurology. 2008;71:1084-1089.
23. Biffi A, Battey TW, Ayres AM, Cortellini L, Schwab K, Gilson AJ, et al. Warfarin-related intraventricular hemorrhage: imaging and outcome. Neurology. 2011;77:1840-1846.
24. van Beijnum J, Lovelock CE, Cordonnier C, Rothwell PM, Klijn CJ, Al-Shahi Salman R. Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies. Brain. 2009;132:537-543.
25. Hemphill JC III, Farrant M, Neill TA Jr. Prospective validation of the ICH score for 12-month functional outcome. Neurology. 2009;73: 1088-1094.
26. Mähönen M, Salomaa V, Keskimäki I, Moltchanov V, Torppa J, Molarius A, et al. The feasibility of combining data from routine hospital discharge and causes-of-death registers for epidemiological studies on stroke. Eur J Epidemiol. 2000;16:815-817. (Pubitemid 32222388)
27. Tolonen H, Salomaa V, Torppa J, Sivenius J, Immonen-Raiha P, Lehtonen A. The validation of the Finnish Hospital Discharge Register and Causes of Death Register data on stroke diagnoses. Eur J Cardiovasc Prev Rehabil. 2007;14:380-385. (Pubitemid 46945560)
28. Meretoja A, Roine RO, Kaste M, Linna M, Juntunen M, Erila T, et al. Stroke monitoring on a national level: PERFECT Stroke, a comprehensive, registry-linkage stroke database in Finland. Stroke. 2010;41: 2239-2246.
29. Meretoja A, Kaste M, Roine RO, Juntunen M, Linna M, Hillbom M, et al. Trends in treatment and outcome of stroke patients in Finland from 1999 to 2007. PERFECT Stroke, a nationwide register study. Ann Med. 2011; 43:S22-S30.